Scholars Central

Short communicationPublished Jul 2021

IMPLICATING IMMUNOTHERAPY IN MYASTHENIA GRAVIS

Authors: Blessie Nelson

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Myasthenia gravis is an autoimmune neuromuscular disorder traditionally seen in bimodal distribution in young women in their 20s-30s or older men in their 60s-70s. Discovery of immunotherapy has brought immense hope in survival outcomes for patients with malignant melanoma, lung, renal and head/neck cancers but it also opens Pandora’s box of immune-related toxicities for which early recognition and appropriate clinical management are paramount. Here we describe a case of immunotherapy induced myasthenia gravis de novo. A 77-year-old man with HPV+ stage IVA squamous cell carcinoma of the tongue presented with sudden onset orthopnea and dyspnea on exertion for the past day. One week ago, he received his second cycle of nivolumab as part of his neoadjuvant therapy. He was seen at an outside hospital and was found to be acute hypercapnic respiratory failure and placed on BiPAP. Additionally

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical & Experimental Radiology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Radiology
  • SubjectRadiology & Imaging
  • BylineArticles whose byline prints “Blessie Nelson”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels